Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Odronextamab |
Trade Name | |
Synonyms | REGN1979 |
Drug Descriptions |
Odronextamab (REGN1979) is a CD20/CD3 bispecific antibody, which targets CD20 expressing cells via T-cell activation, and subsequently leads to cell death (PMID: 26659273). |
DrugClasses | |
CAS Registry Number | 1801338-64-6 |
NCIT ID | C119615 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + Odronextamab | Cemiplimab Odronextamab | 0 | 1 |
Odronextamab | Odronextamab | 0 | 2 |
Odronextamab + REGN5837 | Odronextamab REGN5837 | 0 | 1 |